Patents by Inventor Keith Simmon

Keith Simmon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260092859
    Abstract: Systems, methods, and apparatuses for performing real-time data analytics. One apparatus includes at least one electronic processor and at least one memory storing instructions executable by the at least one electronic processor. The at least one electronic processor is configured to obtain a sequence of cytometry data output by a cytometry instrument, normalize a first data point in the sequence of cytometry data using a set of normalization parameters determined based on a queue of cases belonging to a predetermined class, update the queue of cases belonging to the predetermined class with the normalized first data point in response to determining, using a machine learning model, the normalized first data point belongs to the predetermined class, and normalize a second data point in the sequence of cytometry data using an updated set of normalization parameters determined based on the updated queue of cases belonging to the predetermined class.
    Type: Application
    Filed: October 1, 2025
    Publication date: April 2, 2026
    Inventors: David P. Ng, Lauren Zuromski, Keith Simmon, Jacob Durtschi
  • Publication number: 20230055403
    Abstract: Described herein are methods of identifying a plurality of polynucleotides, as well as detecting presence, absence, or abundance of a plurality of taxa in a sample. Also provided are systems for performing methods of the disclosure.
    Type: Application
    Filed: April 19, 2022
    Publication date: February 23, 2023
    Inventors: Steven Flygare, Keith Simmon, Chase Miller, Yi Qiao, Karen Eilbeck, Gabor Marth, Mark Yandell, Robert Schlaberg
  • Patent number: 11335436
    Abstract: Described herein are methods of identifying a plurality of polynucleotides, as well as detecting presence, absence, or abundance of a plurality of taxa in a sample. Also provided are systems for performing methods of the disclosure.
    Type: Grant
    Filed: October 4, 2017
    Date of Patent: May 17, 2022
    Assignee: University of Utah Research Foundation
    Inventors: Steven Flygare, Keith Simmon, Chase Miller, Yi Qiao, Karen Eilbeck, Gabor Marth, Mark Yandell, Robert Schlaberg
  • Publication number: 20180365375
    Abstract: Described herein are methods of identifying a plurality of polynucleotides, as well as detecting presence, absence, or abundance of a plurality of taxa in a sample. Also provided are systems for performing methods of the disclosure.
    Type: Application
    Filed: October 4, 2017
    Publication date: December 20, 2018
    Inventors: Steven FLYGARE, Keith SIMMON, Chase MILLER, Yi QIAO, Karen EILBECK, Gabor MARTH, Mark YANDELL, Robert SCHLABERG
  • Publication number: 20170364666
    Abstract: At least one of the disclosed embodiments describes a computer system that enables efficient strain typing by comparing strain k-mer profiles to generate a strain typing relationship mapping. The system may include one or more processors, and one or more hardware storage devices with stored computer-executable instructions. The instructions may cause the computer system to receive a set of nucleotide sequence data. The nucleotide sequence data may include a plurality of nucleotide sequence data structures each corresponding to a separate microbial strain to be analyzed. For each nucleotide sequence data structure, a k-mer profile may be generated. K-mer profiles may be compared to determine a similarity score between the k-mer profiles, which may indicate a relationship mapping of the respective microbial strains corresponding to the k-mer profiles.
    Type: Application
    Filed: June 9, 2017
    Publication date: December 21, 2017
    Inventors: Mark Fisher, Keith Simmon
  • Patent number: 8518959
    Abstract: The invention relates to methods of screening for binding partners, especially binding partners essential for the biological activity of erastin (e.g. VDACs such as VDAC3). The invention also provides reagents and methods for effective killing of cancer cells with erastin and related compounds or derivatives.
    Type: Grant
    Filed: January 25, 2006
    Date of Patent: August 27, 2013
    Assignee: Prolexys Pharmaceuticals, Inc.
    Inventors: Robert R. Becklin, Cindy Lou Chepanoske, John M. Peltier, Longwu Qi, Paul B. Robbins, Sudhir R. Sahasrabudhe, Robert Selliah, Keith Simmon, Brent R. Stockwell, Raj Gopal Venkat, Moritz von Rechenberg, Eugene Y. Zhen
  • Publication number: 20090214465
    Abstract: The invention relates to methods of screening for binding partners, especially binding partners essential for the biological activity of erastin (e.g. VDACs such as VDAC3). The invention also provides reagents and methods for effective killing of cancer cells with erastin and related compounds or derivatives.
    Type: Application
    Filed: January 25, 2006
    Publication date: August 27, 2009
    Applicants: PROLEXYS PHARMACEUTICALS, INC., WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH, THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF
    Inventors: Robert R. Becklin, Cindy Lou Chepanoske, John M. Peltier, Longwu Qi, Paul B. Robbins, Sudhir R. Sahasrabudhe, Robert Selliah, Keith Simmon, Brent R. Stockwell, Raj Gopal Venkat, Moritz von Rechenberg, Eugene Y. Zhen